Novel Insights into Actions of Bisphosphonates on Bone: Differences in Interactions with Hydroxyapatite

Nancollas, G.H., Tang, R., Phipps, R.J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R.G.G. +1 more·2006·Bone
DOI 10.1016/j.bone.2005.05.003

Cited by (865)

Items 101–200 of 865

  1. Advanced Drug Delivery Vectors with Tailored Surface Properties Made of Mesoporous Binary Oxides Submicronic Spheres
    Montserrat Colilla, Miguel Manzano, Isabel Izquierdo‐Barba, María Vallet‐Regí, Cédric Boissière, Clément Sánchez · 2009 · Chemistry of Materials
  2. Current concepts in osteogenesis imperfecta: Bone structure, biomechanics and medical management
    Wouter H. Nijhuis, Deborah M. Eastwood, Jeremy Allgrove, Ivan Hvid, Harrie Weinans, Ruud A. Bank, Ralph J. B. Sakkers · 2019 · Journal of Children s Orthopaedics
  3. NMR Investigations of the Static and Dynamic Structures of Bisphosphonates on Human Bone: a Molecular Model
    Sujoy Mukherjee, Yongcheng Song, Eric Oldfield · 2008 · Journal of the American Chemical Society
  4. Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals
    Michele Iafisco, Barbara Palazzo, Marco Marchetti, Nicola Margiotta, Rosa Ostuni, Giovanni Natile, Margherita Morpurgo, Valentina Gandin, Cristina Marzano, Norberto Roveri · 2009 · Journal of Materials Chemistry
  5. Atypical Femoral Fractures: What Do We Know About Them?
    Aasis Unnanuntana, Anas Saleh, Kofi A. Mensah, John P. Kleimeyer, Joseph M. Lane · 2013 · Journal of Bone and Joint Surgery
  6. Drug Insight: bisphosphonates for postmenopausal osteoporosis
    Roland D Chapurlat, Pierre Dominique Delmas · 2006 · Nature Clinical Practice Endocrinology &#38 Metabolism
  7. Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment
    Yanfei L. Ma, Qing Qiang Zeng, Alan Y. Chiang, David B. Burr, Jiliang Li, Harald Dobnig, Astrid Fahrleitner‐Pammer, Dana Michalská, Fernando Marín, Imre J. Pavo et al. · 2013 · Bone
  8. Natural Promoters of Calcium Oxalate Monohydrate Crystallization
    Sahar Farmanesh, Jihae Chung, Ricardo D. Sosa, Jun Ha Kwak, Pankaj Karande, Jeffrey D. Rimer · 2014 · Journal of the American Chemical Society
  9. Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
    Benjamin Z. Leder · 2018 · JBMR Plus
  10. Bisphosphonate actions: Physical chemistry revisited
    Socrates E. Papapoulos · 2006 · Bone
  11. Bone’s Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment
    Yohann Bala, Ego Seeman · 2015 · Calcified Tissue International
  12. Bisphosphonate‐Functionalized Scaffolds for Enhanced Bone Regeneration
    Yutao Cui, Tongtong Zhu, Di Li, Zuhao Li, Yi Leng, Xuan Ji, He Liu, Dankai Wu, Jianxun Ding · 2019 · Advanced Healthcare Materials
  13. Bisphosphonates, Old Friends of Bones and New Trends in Clinics
    Jéssica S. Barbosa, Filipe A. Almeida Paz, Susana Santos Braga · 2021 · Journal of Medicinal Chemistry
  14. Near-infrared fluorescent probe traces bisphosphonate delivery and retention in vivo
    Kenneth M. Kozloff, Leo I. Volakis, Joan C. Marini, Michelle S. Caird · 2010 · Journal of Bone and Mineral Research
  15. Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases
    Rafael T. M. de Rosales, Ciara M. Finucane, S. J. Mather, Philip J. Blower · 2009 · Chemical Communications
  16. Alendronate and Pamidronate calcium phosphate bone cements: Setting properties and in vitro response of osteoblast and osteoclast cells
    Silvia Panzavolta, Paola Torricelli, Barbara Bracci, Milena Fini, Adriana Bigi · 2008 · Journal of Inorganic Biochemistry
  17. Bisphosphonates and bone quality
    Michael Pazianas, Stefan A.P. van der Geest, Paul D. Miller · 2014 · BoneKEy Reports
  18. Determinants of structure–function relationships among bisphosphonates
    R.G.G. Russell · 2007 · Bone
  19. Comparison of Different Intravenous Bisphosphonate Regimens for Paget's Disease of Bone
    Daniela Merlotti, Luigi Gennari, Giuseppe Martini, Fabrizio Valleggi, Vincenzo De Paola, Annalisa Avanzati, Ranuccio Nuti · 2007 · Journal of Bone and Mineral Research
  20. Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis
    Antonios Valachis, Nikolaos P. Polyzos, Robert Edward Coleman, Michael Gnant, Holger Eidtmann, Adam Brufsky, Rebecca Aft, Amye Juliet Tevaarwerk, Karen K. Swenson, Pehr Lind et al. · 2013 · The Oncologist
  21. Teriparatide in the management of osteoporosis
    Riggs · 2008 · Clinical Interventions in Aging
  22. Combination therapy with risedronate and teriparatide in male osteoporosis
    Marcella Donovan Walker, Natalie Elissa Cusano, James Sliney, Megan E. Romano, Chiyuan Amy Zhang, Donald J. McMahon, John Paul Bilezikian · 2012 · Endocrine
  23. A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum
    Edward R. Smith, Tim D. Hewitson, Michael MX Cai, Parisa Aghagolzadeh, Matthias Bachtler, Andreas Pasch, Stephen Geoffrey Holt · 2017 · Scientific Reports
  24. Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
    Oliver Bock · 2008 · Clinical Interventions in Aging
  25. Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid
    Janet Elizabeth Brown, Susan P. Ellis, J. Lester, Sandra A. Gutcher, Tina Khanna, Om Pra-Kesh Purohit, Eugene Vincent McCloskey, Robert Edward Coleman · 2007 · Clinical Cancer Research
  26. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study
    Makoto Kajizono, Hikaru Sada, Yuhko Sugiura, Yoshihiko Soga, Yoshihisa Kitamura, Junji Matsuoka, Toshiaki Sendo · 2015 · Biological and Pharmaceutical Bulletin
  27. Osteoporosis and osteopenia: implications for periodontal and implant therapy
    Joan Otomo‐Corgel · 2012 · Periodontology 2000
  28. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs
    Matthew R. Allen, Daniel J. Kubek, David B. Burr · 2009 · Journal of Bone and Mineral Research
  29. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells
    Yahya Açil, Björn Möller, Peter Niehoff, K. Rachko, Volker Gaßling, J. Wiltfang, Maciej J. K. Simon · 2011 · Journal of Cranio-Maxillofacial Surgery
  30. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy
    Jennifer M Bell, Michael David Shields, Janet Watters, Alistair Hamilton, Timothy R. O. Beringer, Mark Elliott, Rosaline C. M. Quinlivan, Sandya Tirupathi, Bronagh Blackwood · 2017 · Cochrane Database of Systematic Reviews
  31. Natural-Abundance43Ca Solid-State NMR Spectroscopy of Bone
    Jiadi Xu, Peizhi Zhu, Zhehong Gan, Nadder D. Sahar, Mary M. J. Tecklenburg, Michael D. Morris, David H. Kohn, Ayyalusamy Ramamoorthy · 2010 · Journal of the American Chemical Society
  32. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation
    Regina Ebert, Sabine Zeck, Ralf Krug, Jutta Meißner-Weigl, Doris Schneider, Lothar Seefried, J. Eulert, Franz Josef Jakob · 2009 · Bone
  33. Calcium Phosphates as Delivery Systems for Bisphosphonates
    Adriana Bigi, Elisa Boanini · 2018 · Journal of Functional Biomaterials
  34. A Facile One-Stage Treatment of Critical Bone Defects Using a Calcium Sulfate/hydroxyapatite Biomaterial Providing Spatiotemporal Delivery of Bone Morphogenic Protein-2 and Zoledronic Acid
    Raina, Deepak Bushan, Matuszewski, Lucas-Maximilian, Vater, Corina, Bolte, Julia, Isaksson, Hanna, Lidgren, Lars, Tägil, Magnus, Zwingenberger, Stefan · 2020 · Science Advances
  35. Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
    Zachary S. Bernstein, E. Bridget Kim, Noopur S Raje · 2022 · Cells
  36. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: Results from quantitative computed tomography-based finite element analysis of the vertebral body
    Yan Chevalier, Evelyn Quek, Babul Borah, Gary J. Gross, John A. Stewart, Thomas Lang, Philippe K. Zysset · 2009 · Bone
  37. The critical role of bisphosphonates to target bone cancer metastasis: an overview
    Tejinder Singh, Veerpal Kaur, Manish Kumar, Prabhjot Kaur, R. S. R. Murthy, Ravindra Kumar Rawal · 2014 · Journal of drug targeting
  38. Alendronate Improves Screw Fixation in Osteoporotic Bone
    Antonio Moroni, Cesare Faldini, Amy Hoang‐Kim, Francesco Pegreffi, Sandro Giannini · 2007 · Journal of Bone and Joint Surgery
  39. Is There a Role for Bisphosphonates in Chronic Kidney Disease?
    Paul D. Miller · 2007 · Seminars in Dialysis
  40. Recent advances in bone-targeted therapy
    Chen Shi, Tingting Wu, Yu He, Yu Zhang, Dehao Fu · 2020 · Pharmacology & Therapeutics
  41. Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates
    Michele Iafisco, Barbara Palazzo, Gianmario Martra, Nicola Margiotta, Sara Piccinonna, Giovanni Natile, Valentina Gandin, Cristina Marzano, Norberto Roveri · 2011 · Nanoscale
  42. Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
    Win Min Oo, David John Hunter · 2022 · Therapeutic Advances in Musculoskeletal Disease
  43. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review
    André Ferreira Leite, Paulo Tadeu de Souza Figueiredo, Nilce Santos de Melo, Ana Carolina Acevedo, Marcelo Gusmão Paraíso Cavalcanti, Lílian Marly de Paula, Ana Patrícia de Paula, Eliete Neves Silva Guerra · 2006 · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
  44. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics
    Farah Benyettou, Yoann Lalatonne, Imène Chebbi, Mélanie Di Benedetto, Jean‐Michel Serfaty, Marc Lecouvey, Laurence Motte · 2011 · Physical Chemistry Chemical Physics
  45. Zoledronate
    Ian R. Reid, Jonathan R. Green, Kenneth W. Lyles, David M. Reid, U. Trechsel, David J. Hosking, Dennis M. Black, Steven Ron Cummings, R.G.G. Russell, Erik Fink Eriksen · 2020 · Bone
  46. Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases
    Giovanni Storto, Michele Klain, Gaetano Paone, Raffaele Liuzzi, Leonardo Molino, Alfredo Marinelli, Andrea Soricelli, Leonardo Pace, Marco Salvatore · 2006 · Bone
  47. Characterization and Properties of Novel Gallium-Doped Calcium Phosphate Ceramics
    Charlotte Mellier, Franck Fayon, Verena Schnitzler, Philippe Deniard, Mathieu M. B. Allix, S. Quillard, Dominique Massiot A, Jean‐Michel Bouler, Bruno Bujoli, Pascal Janvier · 2011 · Inorganic Chemistry
  48. The effect of alendronate on progression of spinal osteophytes and disc-space narrowing
    Tuhina Neogi, Michael C. Nevitt, Kristine E. Ensrud, Douglas C. Bauer, David T. Felson · 2008 · Annals of the Rheumatic Diseases
  49. Phosphonic Acid-Functionalized Polyurethane Dispersions with Improved Adhesion Properties
    Laura Breucker, Katharina Landfester, Andreas Taden · 2015 · ACS Applied Materials & Interfaces
  50. The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro
    Elisa Boanini, Paola Torricelli, Massimo Gazzano, Milena Fini, Adriana Bigi · 2011 · Biomaterials
  51. Physiology of the aging bone and mechanisms of action of bisphosphonates
    Dominguez, Ligia J., Di Bella, Giovanna, Belvedere, Mario, Barbagallo, Mario · 2011 · Biogerontology
  52. Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer
    Wei‐Ming Li, Chih‐Sheng Chiang, Wei-Chen Huang, Chia-Wei Su, Min-Yu Chiang, Jian-Yi Chen, San‐Yuan Chen · 2015 · Journal of Controlled Release
  53. Bisphosphonate coating on titanium screws increases mechanical fixation in rat tibia after two weeks
    Karin Wermelin, Per Aspenberg, Paula Linderbäck, Pentti Tengvall · 2007 · Journal of Biomedical Materials Research Part A
  54. Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses
    Elisa Boanini, Paola Torricelli, Massimo Gazzano, Elena Della Bella, Milena Fini, Adriana Bigi · 2014 · Biomaterials
  55. Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum–bisphosphonate complexes in the treatment of bone tumors: A mini-review
    Michele Iafisco, Nicola Margiotta · 2012 · Journal of Inorganic Biochemistry
  56. CT Imaging Features of Antiresorptive agent-Related Osteonecrosis of the Jaw/ Medication-Related Osteonecrosis of the Jaws
    Akira Baba, Tazuko K. Goto, Hiroya Ojiri, Mutsumi Takagiwa, Chiho Hiraga, Masahiro Okamura, Sho Hasegawa, Yumi Okuyama, Nobuhiro Ogino, Hideomi Yamauchi et al. · 2018 · Dentomaxillofacial Radiology
  57. Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis
    Hennie G. Raterman, Irene E. M. Bultink, Willem Frederik Lems · 2019 · Drugs
  58. Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolutionin vitro
    Zachary J. Henneman, George H. Nancollas, Frank H. Ebetino, R.G.G. Russell, Roger J. Phipps · 2007 · Journal of Biomedical Materials Research Part A
  59. Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
    Irene V. Lambrinoudaki · 2008 · Clinical Interventions in Aging
  60. Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
    Jan J. Stepan, David B. Burr, Jiliang Li, Y. L. Ma, Helmut Petto, A. Sipos, Harald Dobnig, Astrid Fahrleitner‐Pammer, Dana Michalská, Imre J. Pavo · 2010 · Osteoporosis International
  61. Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma
    Victoria Wu, Jarrett Mickens, Vuk Uskoković · 2017 · ACS Applied Materials & Interfaces
  62. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties
    Deepak Bushan Raina, David Larsson, Filip Mrkonjic, Hanna Isaksson, Ashok Kumar, Lars Lidgren, Magnus Tägil · 2018 · Journal of Controlled Release
  63. Functionalization of biomimetic calcium phosphate bone cements with alendronate
    Silvia Panzavolta, Paola Torricelli, Barbara Bracci, Milena Fini, Adriana Bigi · 2010 · Journal of Inorganic Biochemistry
  64. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model
    Neashan Mathavan, Per Bosemark, Hanna Isaksson, Magnus Tägil · 2013 · Bone
  65. Bisphosphonates for post-menopausal osteoporosis: are they all the same?
    René Rizzoli · 2011 · QJM
  66. Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S‐phase arrest, in human myeloma cells
    Anke J. Roelofs, P A Hulley, Annemieke Meijer, Frank H. Ebetino, R.G.G. Russell, C M Shipman · 2006 · International Journal of Cancer
  67. The facile synthesis of zoledronate functionalized hydroxyapatite amorphous hybrid nanobiomaterial and its excellent removal performance on Pb2+ and Cu2+
    Xiaojie Fang, Sidi Zhu, Jianzhe Ma, Fengyun Wang, Haihua Xu, Mingzhu Xia · 2020 · Journal of Hazardous Materials
  68. Interaction between a Bisphosphonate, Tiludronate, and Biomimetic Nanocrystalline Apatites
    Patricia Pascaud-Mathieu, Pierre Gras, Yannick Coppel, Christian C. Rey, Stéphanie Sarda · 2013 · Langmuir
  69. Superparamagnetic nanovector with anti-cancer properties: γFe2O3@Zoledronate
    Farah Benyettou, Yoann Lalatonne, Odile Sainte‐Catherine, Maëlle Monteil, Laurence Motte · 2009 · International Journal of Pharmaceutics
  70. Statins and Protein Prenylation in Cancer Cell Biology and Therapy
    Carmen García‐Ruiz, Albert Morales, José Carlos Fernández-Checa · 2012 · Anti-Cancer Agents in Medicinal Chemistry
  71. Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
    Yasuo Endo, Hiroyuki Kumamoto, Masanori Nakamura, Shunji Sugawara, Teruko Takano‐Yamamoto, Keiichi Sasaki, Tetsu Takahashi · 2017 · Biological and Pharmaceutical Bulletin
  72. Updated approach for the management of osteoporosis in Turkey: a consensus report
    Yeşim Kirazlı, Funda Atamaz Çalış, Özlem El, Yeşim Gökçe Kutsal, Özlen Peker, Dilşad Sindel, Şansın Tüzün, Dilek Gogaş Yavuz, Berrin Durmaz, Ülkü Akarırmak et al. · 2020 · Archives of Osteoporosis
  73. Chemical synthesis and characterization of hydroxyapatite (HAp)-poly (ethylene co vinyl alcohol) (EVA) nanocomposite using a phosphonic acid coupling agent for orthopedic applications
    Nabakumar Pramanik, Sasmita Mohapatra, Parag Bhargava, Panchanan Pramanik · 2008 · Materials Science and Engineering C
  74. Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
    Athanasios D. Anastasilakis, Stergios A. Pοlyzos, Athina I. Gkiomisi, Zacharias G. Saridakis, D. Digkas, Ilias Bisbinas, Grigorios Theocharis Sakellariou, Αθανάσιος Παπαθεοδώρου, Panagiotis Kokkoris, Polyzois Makras · 2015 · Osteoporosis International
  75. Osteoporotic Vertebral Fractures During Pregnancy: Be Aware of a Potential Underlying Genetic Cause
    Natalia Campos‐Obando, Ling Oei, Lies H. Hoefsloot, Rosalie M. Kiewiet, Caroline C. W. Klaver, Marleen Simon, M. Carola Zillikens · 2014 · The Journal of Clinical Endocrinology & Metabolism
  76. Zoledronic Acid
    Sohita Dhillon, Katherine Ann Lyseng-Williamson · 2008 · Drugs
  77. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
    Margaret Paggiosi, Nicola F. A. Peel, Eugene Vincent McCloskey, Jennifer Walsh, Richard Eastell · 2014 · Osteoporosis International
  78. Adsorption on apatitic calcium phosphates for drug delivery: interaction with bisphosphonate molecules
    Patricia Pascaud-Mathieu, Farid Errassifi, Fabien Brouillet, Stéphanie Sarda, Allal Barroug, Ahmed Legrouri, Christian C. Rey · 2014 · Journal of Materials Science Materials in Medicine
  79. Effects of Functionalized Gold Nanoparticle Size on X-ray Attenuation and Substrate Binding Affinity
    Ryan D. Ross, Lisa E. Cole, Jennifer M. R. Tilley, Ryan K. Roeder · 2013 · Chemistry of Materials
  80. A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone
    Deepak Bushan Raina, Hanna Isaksson, Werner Herbert Hettwer, Ashok Kumar, Lars Lidgren, Magnus Tägil · 2016 · Scientific Reports
  81. Highly Porous Amorphous Calcium Phosphate for Drug Delivery and Bio-Medical Applications
    Rui Sun, Michelle Åhlén, Cheuk‐Wai Tai, Éva G. Bajnóczi, Fenne de Kleijne, Natália Ferraz, Ingmar Persson, Maria Strømme, Ocean Y. H. Cheung · 2019 · Nanomaterials
  82. Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk
    Jeffrey R. Curtis, Kenneth G. Saag, Tarun Arora, Nicole C. Wright, Huifeng Yun, Shanette G. Daigle, Robert Matthews, Elizabeth Delzell · 2020 · Medical Care
  83. Osteoclastic bone resorption induced by innate immune responses
    Masanori Koide, Saya Kinugawa, Naoyuki Takahashi, Nobuyuki Udagawa · 2010 · Periodontology 2000
  84. Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
    Luca Dalle Carbonare, Mirko Zanatta, Adriano Gasparetto, Maria Teresa Valenti · 2010 · Drug Healthcare and Patient Safety
  85. Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates
    Sylvia Thiele, Martina Rauner, Claudia Goettsch, Tilman D. Rachner, Peggy Benad, Susanne Fuessel, Kati Erdmann, Christine Hamann, Gustavo Bruno Baretton, Manfred Peter Wirth et al. · 2011 · Journal of Cellular Biochemistry
  86. Synthesis, Chiral High Performance Liquid Chromatographic Resolution and Enantiospecific Activity of a Potent New Geranylgeranyl Transferase Inhibitor, 2-Hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic Acid
    Charles E. McKenna, B. A. Kashemirov, K. M. Błażewska, Isabelle Mallard, Charlotte A. Stewart, Javier Rojas, Mark Walden Lundy, Frank H. Ebetino, Rudi Baron, James E. Dunford et al. · 2010 · Journal of Medicinal Chemistry
  87. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy
    Baojie Li, Jenny Fung Ling Chau, Yuqin Wang, Wai Fook Leong · 2011 · Journal of Cellular Biochemistry
  88. Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs)
    Daniel Holzinger, Rudolf Seemann, Clemens Klug, Rolf Ewers, G. Millesi, Arnulf Baumann, Arno Wutzl · 2012 · Oral Oncology
  89. Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate
    Yohann Bala, Delphine Farlay, Roland D Chapurlat, Georges Boivin · 2011 · European Journal of Endocrinology
  90. Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw
    Shirin Kalyan, Jun Wang, Elgar Susanne Quabius, Jörn Huck, Jörg Wiltfang, John F. Baines, Dieter Kabelitz · 2015 · Journal of Translational Medicine
  91. Corrosion and degradation decelerating alendronate embedded zinc phosphate hybrid coating on biodegradable Zn biomaterials
    Xiaoshan Mo, Junyu Qian, Yingqi Chen, Wentai Zhang, Peng Xian, Shuai Tang, Chao Yu Zhou, Nan Huang, Huanzhong Ji, En Luo et al. · 2021 · Corrosion Science
  92. Reaction of Zoledronate with β-Tricalcium Phosphate for the Design of Potential Drug Device Combined Systems
    Hélène Roussière, Franck Fayon, Bruno Pierre Bernard Alonso, Thierry Rouillon, Verena Schnitzler, Élise Verron, Jérôme Guicheux, Marc Petit, Dominique Massiot A, Pascal Janvier et al. · 2007 · Chemistry of Materials
  93. Enhanced bone morphogenetic protein‐2 performance on hydroxyapatite ceramic surfaces
    Andrea Schuessele, Helmar Mayr, Jörg Teßmar, Achim M. Göpferich · 2008 · Journal of Biomedical Materials Research Part A
  94. Modeling and spectroscopic studies of bisphosphonate–bone interactions. The Raman, NMR and crystallographic investigations of Ca–HEDP complexes
    Ignacy Cukrowski, Ljiljana Popović, Werner Barnard, Sylvia O. Paul, Petrus H. Van Rooyen, David C. Liles · 2007 · Bone
  95. Ab initio Investigation of Adsorption Characteristics of Bisphosphonates on Hydroxyapatite (001) Surface
    Mun-Hyok Ri, Yong-Man Jang, Un-Son Ri, Chol‐Jun Yu, Kyong-Il Kim, Song-Un Kim · 2017 · Journal of Materials Science
  96. Synthesis and biological activities of drugs for the treatment of osteoporosis
    Shiyang Zhou, Gangliang Huang, Guang‐Ying Chen · 2020 · European Journal of Medicinal Chemistry
  97. Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?
    Inés Asunción Losada López, Leonardo Sartori, Elena Di Gianantonio, Margherita Zen, Maurizio Clementi, Andrea Doria · 2010 · Autoimmunity Reviews
  98. Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial
    Athanasios D. Anastasilakis, Stergios A. Pοlyzos, Athina I. Gkiomisi, Ilias Bisbinas, Spyridon Gerou, Polyzois Makras · 2013 · The Journal of Clinical Endocrinology & Metabolism
  99. Anti-resorptives in the management of osteoporosis
    Paul D. Miller · 2008 · Best Practice & Research Clinical Endocrinology & Metabolism
  100. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density
    K.E. Naylor, Mike J Bradburn, Margaret Paggiosi, Fatma Gossiel, Nicola F. A. Peel, Eugene Vincent McCloskey, Jennifer Walsh, Richard Eastell · 2018 · Osteoporosis International